Marketplace

• share
• favorite_border

Cutting-edge dual-laser technology delivers power and precision in one device

• share
• favorite_border

The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in non-clinical/pre-clinical discovery assessment of oligonucleotide drug candidates, clinical trials for immunogenicity studies, and other applications.

• share
• favorite_border

Licensing agreement with Kindstar Globalgene Technology will more than double Wren NETest distribution within first year

• share
• favorite_border

New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Diagnose Autoimmune Diseases, Reducing Time to Diagnosis and Improving Patient Outcomes

• share
• favorite_border

TAU Systems, the producer of ultrafast, compact laser-plasma accelerators, today announced further additions to its senior management team as the company continues on its path to commercial availability of the system.

• share
• favorite_border

ARUP Laboratories today announced the formation of the new ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute). The institute will improve the lives of patients by advancing groundbreaking diagnostic and prognostic technologies and innovative tests.

• share
• favorite_border

New expanded indication will increase home hemodialysis device options available to patients with end-stage kidney disease.

• share
• favorite_border

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

• share
• favorite_border

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform today announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company for the Middle East and North Africa (MENA).

• share
• favorite_border

Waters Corporation (NYSE:WAT) introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

• share
• favorite_border

Developed by OnsiteGene Inc. and sponsored by the NIH RADx initiative, PeakV is a sample-to-answer instrument that transforms PCR testing.

• share
• favorite_border

Prevencio, Inc. today announces the culminative presentation of patient data demonstrating that its Artificial Intelligence (AI)-driven HART® blood tests are highly accurate in a broad range of patients, including those suffering from diabetes, chronic kidney disease, hypertension, obesity, coronary heart disease, heart failure, chronic total occlusion (CTO) of the heart arteries, and Kawasaki disease. The HART platform is disease agnostic and may be used to develop diagnostics beyond cardiac disease.

• share
• favorite_border

Halo Labs, a pioneer in life science instrumentation, announced the launch of its new Aura®+ Subscription Program.